nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorzoxazone—CYP2E1—Parkinson's disease	0.516	0.577	CbGaD
Chlorzoxazone—CYP2D6—Parkinson's disease	0.379	0.423	CbGaD
Chlorzoxazone—KCNMA1—hindbrain—Parkinson's disease	0.000865	0.131	CbGeAlD
Chlorzoxazone—KCNMA1—brainstem—Parkinson's disease	0.000496	0.0751	CbGeAlD
Chlorzoxazone—KCNMA1—forebrain—Parkinson's disease	0.000478	0.0725	CbGeAlD
Chlorzoxazone—KCNMA1—cardiovascular system—Parkinson's disease	0.000404	0.0613	CbGeAlD
Chlorzoxazone—KCNMA1—midbrain—Parkinson's disease	0.000316	0.0478	CbGeAlD
Chlorzoxazone—KCNMA1—head—Parkinson's disease	0.000274	0.0415	CbGeAlD
Chlorzoxazone—CYP2D6—hindbrain—Parkinson's disease	0.00027	0.0409	CbGeAlD
Chlorzoxazone—KCNMA1—nervous system—Parkinson's disease	0.00026	0.0393	CbGeAlD
Chlorzoxazone—KCNMA1—central nervous system—Parkinson's disease	0.00025	0.0379	CbGeAlD
Chlorzoxazone—KCNMA1—cerebellum—Parkinson's disease	0.000244	0.037	CbGeAlD
Chlorzoxazone—CYP2A6—cerebellum—Parkinson's disease	0.000204	0.0309	CbGeAlD
Chlorzoxazone—KCNMA1—brain—Parkinson's disease	0.000198	0.0301	CbGeAlD
Chlorzoxazone—CYP2A6—brain—Parkinson's disease	0.000166	0.0251	CbGeAlD
Chlorzoxazone—CYP2E1—cardiovascular system—Parkinson's disease	0.00016	0.0242	CbGeAlD
Chlorzoxazone—CYP2D6—brainstem—Parkinson's disease	0.000155	0.0235	CbGeAlD
Chlorzoxazone—CYP2D6—forebrain—Parkinson's disease	0.000149	0.0226	CbGeAlD
Chlorzoxazone—CYP2E1—medulla oblongata—Parkinson's disease	0.000136	0.0207	CbGeAlD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000131	0.00134	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00013	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—Parkinson's disease	0.000129	0.00132	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Biological oxidations—GSTM1—Parkinson's disease	0.000127	0.00129	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000126	0.00129	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—CYP2E1—Parkinson's disease	0.000125	0.00127	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000123	0.00125	CbGpPWpGaD
Chlorzoxazone—CYP2E1—spinal cord—Parkinson's disease	0.000122	0.0184	CbGeAlD
Chlorzoxazone—CYP1A1—head—Parkinson's disease	0.000119	0.018	CbGeAlD
Chlorzoxazone—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000117	0.00119	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000116	0.00118	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000114	0.00116	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000113	0.00115	CbGpPWpGaD
Chlorzoxazone—CYP1A1—nervous system—Parkinson's disease	0.000112	0.017	CbGeAlD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000112	0.00114	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—COMT—Parkinson's disease	0.00011	0.00112	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	0.000109	0.00111	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	0.000109	0.00111	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	0.000108	0.0011	CbGpPWpGaD
Chlorzoxazone—CYP1A1—central nervous system—Parkinson's disease	0.000108	0.0164	CbGeAlD
Chlorzoxazone—CYP2E1—head—Parkinson's disease	0.000108	0.0164	CbGeAlD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000108	0.0011	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—COMT—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTP1—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—MAOA—Parkinson's disease	0.000103	0.00105	CbGpPWpGaD
Chlorzoxazone—CYP2E1—nervous system—Parkinson's disease	0.000102	0.0155	CbGeAlD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—COMT—Parkinson's disease	0.000102	0.00104	CbGpPWpGaD
Chlorzoxazone—KCNMA1—Circadian rythm related genes—IL6—Parkinson's disease	0.000102	0.00104	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000102	0.00103	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000101	0.00103	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	0.0001	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.0001	0.00102	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	9.9e-05	0.00101	CbGpPWpGaD
Chlorzoxazone—CYP2E1—central nervous system—Parkinson's disease	9.87e-05	0.0149	CbGeAlD
Chlorzoxazone—CYP2E1—cerebellum—Parkinson's disease	9.64e-05	0.0146	CbGeAlD
Chlorzoxazone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	9.52e-05	0.000969	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Biological oxidations—GSTM1—Parkinson's disease	9.46e-05	0.000963	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	9.4e-05	0.000957	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metapathway biotransformation—GSTM1—Parkinson's disease	9.33e-05	0.00095	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	9.27e-05	0.000944	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	9.09e-05	0.000925	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	9.04e-05	0.00092	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ND3—Parkinson's disease	9.01e-05	0.000917	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MCCC1—Parkinson's disease	9.01e-05	0.000917	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	8.71e-05	0.000886	CbGpPWpGaD
Chlorzoxazone—CYP1A1—brain—Parkinson's disease	8.59e-05	0.013	CbGeAlD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.59e-05	0.000874	CbGpPWpGaD
Chlorzoxazone—CYP2D6—head—Parkinson's disease	8.56e-05	0.013	CbGeAlD
Chlorzoxazone—CYP2A6—Metabolism—TALDO1—Parkinson's disease	8.47e-05	0.000862	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—OMD—Parkinson's disease	8.47e-05	0.000862	CbGpPWpGaD
Chlorzoxazone—CYP3A4—nervous system—Parkinson's disease	8.25e-05	0.0125	CbGeAlD
Chlorzoxazone—CYP2D6—nervous system—Parkinson's disease	8.12e-05	0.0123	CbGeAlD
Chlorzoxazone—CYP2A6—Metabolism—NDUFB11—Parkinson's disease	8.03e-05	0.000817	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	7.96e-05	0.000811	CbGpPWpGaD
Chlorzoxazone—CYP3A4—central nervous system—Parkinson's disease	7.94e-05	0.012	CbGeAlD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.85e-05	0.000799	CbGpPWpGaD
Chlorzoxazone—CYP2E1—brain—Parkinson's disease	7.83e-05	0.0119	CbGeAlD
Chlorzoxazone—CYP2D6—central nervous system—Parkinson's disease	7.81e-05	0.0118	CbGeAlD
Chlorzoxazone—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.79e-05	0.000793	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.75e-05	0.000789	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.73e-05	0.000787	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.68e-05	0.000782	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GCH1—Parkinson's disease	7.66e-05	0.00078	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.65e-05	0.000778	CbGpPWpGaD
Chlorzoxazone—CYP2D6—cerebellum—Parkinson's disease	7.64e-05	0.0116	CbGeAlD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.28e-05	0.000741	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.13e-05	0.000725	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	7.12e-05	0.000725	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ND3—Parkinson's disease	7.12e-05	0.000724	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MCCC1—Parkinson's disease	7.12e-05	0.000724	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	7.03e-05	0.000715	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—FBP1—Parkinson's disease	6.83e-05	0.000695	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GBA—Parkinson's disease	6.83e-05	0.000695	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—DBH—Parkinson's disease	6.83e-05	0.000695	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.72e-05	0.000684	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MCCC1—Parkinson's disease	6.71e-05	0.000683	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ND3—Parkinson's disease	6.71e-05	0.000683	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TALDO1—Parkinson's disease	6.69e-05	0.000681	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—OMD—Parkinson's disease	6.69e-05	0.000681	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.63e-05	0.000675	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.6e-05	0.000672	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.6e-05	0.000671	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.6e-05	0.000671	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.57e-05	0.000668	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.55e-05	0.000667	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	6.51e-05	0.000662	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	6.48e-05	0.000659	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	6.34e-05	0.000646	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—OMD—Parkinson's disease	6.31e-05	0.000642	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TALDO1—Parkinson's disease	6.31e-05	0.000642	CbGpPWpGaD
Chlorzoxazone—CYP2D6—brain—Parkinson's disease	6.2e-05	0.0094	CbGeAlD
Chlorzoxazone—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	6.15e-05	0.000626	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	6.06e-05	0.000617	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GCH1—Parkinson's disease	6.05e-05	0.000616	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	6.03e-05	0.000614	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NDUFB11—Parkinson's disease	5.98e-05	0.000609	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	5.95e-05	0.000606	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GCH1—Parkinson's disease	5.71e-05	0.000581	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—FBP1—Parkinson's disease	5.39e-05	0.000549	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GBA—Parkinson's disease	5.39e-05	0.000549	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—DBH—Parkinson's disease	5.39e-05	0.000549	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.15e-05	0.000524	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—COMT—Parkinson's disease	5.09e-05	0.000518	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GBA—Parkinson's disease	5.09e-05	0.000518	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—FBP1—Parkinson's disease	5.09e-05	0.000518	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—DBH—Parkinson's disease	5.09e-05	0.000518	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	5.07e-05	0.000516	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	5.06e-05	0.000515	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ND3—Parkinson's disease	5.05e-05	0.000514	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MCCC1—Parkinson's disease	5.05e-05	0.000514	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	5.02e-05	0.000511	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—DDC—Parkinson's disease	5.01e-05	0.00051	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	5e-05	0.000509	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.75e-05	0.000483	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—OMD—Parkinson's disease	4.75e-05	0.000483	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTA4—Parkinson's disease	4.73e-05	0.000482	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.66e-05	0.000474	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.59e-05	0.000468	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.54e-05	0.000463	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.5e-05	0.000458	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GCH1—Parkinson's disease	4.29e-05	0.000437	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MCCC1—Parkinson's disease	4.28e-05	0.000436	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ND3—Parkinson's disease	4.28e-05	0.000436	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—PLA2G6—Parkinson's disease	4.26e-05	0.000434	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MAOB—Parkinson's disease	4.22e-05	0.000429	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—OMD—Parkinson's disease	4.02e-05	0.000409	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TALDO1—Parkinson's disease	4.02e-05	0.000409	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—DDC—Parkinson's disease	3.96e-05	0.000403	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GBA—Parkinson's disease	3.83e-05	0.00039	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.83e-05	0.00039	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—DBH—Parkinson's disease	3.83e-05	0.00039	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.81e-05	0.000388	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTA4—Parkinson's disease	3.74e-05	0.000381	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—DDC—Parkinson's disease	3.73e-05	0.00038	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.64e-05	0.00037	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTA4—Parkinson's disease	3.53e-05	0.000359	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.48e-05	0.000354	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	3.37e-05	0.000343	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MAOB—Parkinson's disease	3.33e-05	0.000339	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ND3—Parkinson's disease	3.3e-05	0.000336	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.3e-05	0.000336	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.28e-05	0.000334	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—FBP1—Parkinson's disease	3.24e-05	0.00033	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—DBH—Parkinson's disease	3.24e-05	0.00033	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GBA—Parkinson's disease	3.24e-05	0.00033	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—PLA2G6—Parkinson's disease	3.17e-05	0.000323	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MAOB—Parkinson's disease	3.14e-05	0.00032	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP2D6—Parkinson's disease	3.13e-05	0.000319	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—OMD—Parkinson's disease	3.1e-05	0.000316	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.1e-05	0.000316	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CTGF—Parkinson's disease	3.08e-05	0.000313	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.99e-05	0.000304	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.94e-05	0.0003	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYP2E1—Parkinson's disease	2.87e-05	0.000292	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—NQO1—Parkinson's disease	2.83e-05	0.000289	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—DDC—Parkinson's disease	2.81e-05	0.000286	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.81e-05	0.000286	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—TH—Parkinson's disease	2.79e-05	0.000284	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—CYCS—Parkinson's disease	2.68e-05	0.000273	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.65e-05	0.00027	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.5e-05	0.000255	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GBA—Parkinson's disease	2.5e-05	0.000255	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—DBH—Parkinson's disease	2.5e-05	0.000255	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	2.48e-05	0.000252	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CTGF—Parkinson's disease	2.43e-05	0.000247	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.39e-05	0.000243	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—DDC—Parkinson's disease	2.38e-05	0.000242	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—COMT—Parkinson's disease	2.38e-05	0.000242	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.36e-05	0.000241	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTP1—Parkinson's disease	2.36e-05	0.000241	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MAOA—Parkinson's disease	2.36e-05	0.00024	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP2D6—Parkinson's disease	2.34e-05	0.000238	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—HMOX1—Parkinson's disease	2.33e-05	0.000237	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CTGF—Parkinson's disease	2.29e-05	0.000233	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.25e-05	0.000229	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—NQO1—Parkinson's disease	2.24e-05	0.000228	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—ABCB1—Parkinson's disease	2.24e-05	0.000228	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.22e-05	0.000226	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—TH—Parkinson's disease	2.21e-05	0.000225	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GSTM1—Parkinson's disease	2.17e-05	0.000221	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYP2E1—Parkinson's disease	2.14e-05	0.000217	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—CYCS—Parkinson's disease	2.12e-05	0.000216	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—NQO1—Parkinson's disease	2.11e-05	0.000215	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—TH—Parkinson's disease	2.08e-05	0.000212	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—GPX1—Parkinson's disease	2.08e-05	0.000212	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	2.02e-05	0.000206	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MAOB—Parkinson's disease	2e-05	0.000204	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—CYCS—Parkinson's disease	2e-05	0.000203	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—MTHFR—Parkinson's disease	1.92e-05	0.000195	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.91e-05	0.000194	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—COMT—Parkinson's disease	1.88e-05	0.000191	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.87e-05	0.00019	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.86e-05	0.00019	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.84e-05	0.000188	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—DDC—Parkinson's disease	1.84e-05	0.000187	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—APOE—Parkinson's disease	1.79e-05	0.000182	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—COMT—Parkinson's disease	1.77e-05	0.00018	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.77e-05	0.00018	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTP1—Parkinson's disease	1.76e-05	0.000179	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MAOA—Parkinson's disease	1.76e-05	0.000179	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—HMOX1—Parkinson's disease	1.74e-05	0.000177	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.73e-05	0.000177	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.73e-05	0.000176	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.72e-05	0.000175	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—ABCB1—Parkinson's disease	1.67e-05	0.00017	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.64e-05	0.000167	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GSTM1—Parkinson's disease	1.62e-05	0.000165	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.61e-05	0.000164	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.59e-05	0.000162	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—TH—Parkinson's disease	1.57e-05	0.000159	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.56e-05	0.000159	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—GPX1—Parkinson's disease	1.55e-05	0.000158	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.55e-05	0.000157	CbGpPWpGaD
Chlorzoxazone—CYP2A6—Metabolism—INS—Parkinson's disease	1.53e-05	0.000155	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.52e-05	0.000154	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.5e-05	0.000153	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.49e-05	0.000152	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.46e-05	0.000149	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—MTHFR—Parkinson's disease	1.43e-05	0.000146	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—APOE—Parkinson's disease	1.41e-05	0.000144	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	0.000139	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.35e-05	0.000137	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—COMT—Parkinson's disease	1.33e-05	0.000136	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—APOE—Parkinson's disease	1.33e-05	0.000136	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—TH—Parkinson's disease	1.33e-05	0.000135	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.33e-05	0.000135	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.32e-05	0.000135	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.31e-05	0.000133	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.27e-05	0.00013	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.25e-05	0.000128	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.22e-05	0.000124	CbGpPWpGaD
Chlorzoxazone—CYP2E1—Metabolism—INS—Parkinson's disease	1.21e-05	0.000123	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.17e-05	0.000119	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.15e-05	0.000117	CbGpPWpGaD
Chlorzoxazone—CYP1A1—Metabolism—INS—Parkinson's disease	1.14e-05	0.000116	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—COMT—Parkinson's disease	1.13e-05	0.000115	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.13e-05	0.000115	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.12e-05	0.000114	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.12e-05	0.000114	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.11e-05	0.000113	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.08e-05	0.00011	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.06e-05	0.000108	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.05e-05	0.000107	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.04e-05	0.000106	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.03e-05	0.000105	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—TH—Parkinson's disease	1.02e-05	0.000104	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—APOE—Parkinson's disease	1e-05	0.000102	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—GPX1—Parkinson's disease	9.88e-06	0.000101	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.83e-06	0.0001	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—MTHFR—Parkinson's disease	9.12e-06	9.28e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—COMT—Parkinson's disease	8.71e-06	8.86e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTP1—Parkinson's disease	8.67e-06	8.82e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MAOA—Parkinson's disease	8.65e-06	8.8e-05	CbGpPWpGaD
Chlorzoxazone—CYP2D6—Metabolism—INS—Parkinson's disease	8.56e-06	8.72e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—HMOX1—Parkinson's disease	8.55e-06	8.7e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—APOE—Parkinson's disease	8.49e-06	8.64e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—ABCB1—Parkinson's disease	8.2e-06	8.35e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.96e-06	8.11e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.63e-06	7.76e-05	CbGpPWpGaD
Chlorzoxazone—CYP1A2—Metabolism—INS—Parkinson's disease	7.25e-06	7.38e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—MTHFR—Parkinson's disease	7.04e-06	7.17e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—APOE—Parkinson's disease	6.55e-06	6.67e-05	CbGpPWpGaD
Chlorzoxazone—CYP3A4—Metabolism—INS—Parkinson's disease	5.6e-06	5.7e-05	CbGpPWpGaD
